Approved HIV reverse transcriptase inhibitors in the past decade
Author:
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference203 articles.
1. Approved antiviral drugs over the past 50 years;De Clercq;Clin Microbiol Rev,2016
2. Fifty years in search of selective antiviral drugs;De Clercq;J Med Chem,2019
3. Role of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infections;De Clercq;Biochem Pharmacol,2018
4. Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment;Wang;Expet Opin Drug Metabol Toxicol,2019
5. Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses;Ma;Chem Soc Rev,2021
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBP;European Journal of Medicinal Chemistry;2024-11
2. Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization;European Journal of Medicinal Chemistry;2024-11
3. Structure-based discovery of novel piperidine-biphenyl-DAPY derivatives as non-nucleoside reverse transcriptase inhibitors featuring improved potency, safety, and selectivity: From piperazine-biphenyl-DAPYs to piperidine-biphenyl-DAPYs;European Journal of Medicinal Chemistry;2024-10
4. The Role of Tumor Suppressor p53 Protein in HIV–Host Cell Interactions;Cells;2024-09-10
5. Computational identification and analysis of CNP0269688 as a natural product inhibitor disrupting the interaction between the HIV matrix domain and tRNA;Frontiers in Chemistry;2024-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3